Endothelin receptor A blockade enhances taxane effects in prostate cancer.

Akhavan, Ardavan; McHugh, Kevin H; Guruli, Georgi; Bies, Robert R; Zamboni, William C; Strychor, Sandra A; Nelson, Joel B; Pflug, Beth R

Akhavan, Ardavan; McHugh, Kevin H; Guruli, Georgi; Bies, Robert R; Zamboni, William C; Strychor, Sandra A; Nelson, Joel B; Pflug, Beth R.

Affiliation

Akhavan A; Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Neoplasia ; 8(9): 725-32, 2006 Sep.

Article in En | MEDLINE | ID: mdl-16984730

Subject(s)

Bridged-Ring Compounds/pharmacology; Endothelin A Receptor Antagonists; Prostatic Neoplasms/drug therapy; Prostatic Neoplasms/metabolism; Taxoids/pharmacology; Animals; Apoptosis; Atrasentan; Cell Survival; Humans; Ki-67 Antigen/biosynthesis; Male; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1/biosynthesis; Pyrrolidines/pharmacology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Bridged-Ring Compounds / Taxoids / Endothelin A Receptor Antagonists Limits: Animals / Humans / Male Language: En Journal: Neoplasia Journal subject: NEOPLASIAS Year: 2006 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google